Beyond Episodic Assessment
May 27th, 2025
The current landscape of drug monitoring is hindered by outdated, episodic assessment methods that fail to capture the dynamic nature of these diseases. lungDx offers an innovative, technology-driven solution for continuous monitoring, leveraging biometric sensors, artificial intelligence (AI), and cloud-based data analytics to revolutionise drug effectiveness evaluation.
electronRx has compiled this white paper to provide a comprehensive overview of the opportunities in pharmaceutical research and treatment, ensuring that drugs on the market deliver their expected benefits and accelerating drug development and clinical validation.
Contents of the white paper:
Advancing COPD Treatment Monitoring: Innovations and Challenges
Continuous Monitoring in Asthma: Improving Drug Efficacy Insights
Real-time Evaluation of ILD Treatments: Moving Beyond Episodic Assessment
Enhancing Pulmonary Hypertension Treatment Assessment Through Continuous Monitoring
Drop your details below and the white paper will be emailed directly to you: